|
|
730 Stockton Drive
Exton, PA 19341 USA
phone:610-458-7300
fax:610-458-7380
|
|
| Symbol |
VPHM |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.viropharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drugs for transplant medicine and gastroenterology. |
|
| Management |
| Colin Broom, Vice President, Chief Scientific Officer; Thomas F. Doyle, Vice President, Strategic Initiatives; Vincent J. Milano, President, Chief Executive Officer And Chairman Of The Board Of Directors; Robert G. Pietrusko, Vice President, Global Regulatory Affairs And Quality; Daniel B Soland, Vice President, Chief Operating Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| hepatitis C, staphylococcus, gastroenterology, transplant medicine |
|
|
|
| Description |
|
ViroPharma Incorporated is a pharmaceutical company focused on the development and commercialization of important medicines to address serious diseases treated by physician specialists, in areas including hospital settings, transplant medicine and gastroenterology. |
|
| Products / Services |
Vancocin Pulvules is an antibiotic approved to treat two significant bacterial infections of the lower digestive tract. The product is indicated for oral administration for treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic-associated pseudomembranous colitis caused by Clostridium difficile.
|
|
|
| Strategy |
ViroPharma is developing three promising core clinical opportunities, maribavir for prevention of cytomegalovirus infection, and two compounds within our hepatitis C franchise, HCV-086 and HCV-796.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
